SHC1 and hepatocellular carcinoma: For example, oncostatin M (OSM), but not IL-6 or LIF, induces the tyrosine phosphorylation of the Shc isoforms p52 and p66 and their association with Grb2, resulting in a stronger activation of ERK signaling in hepatoma cells [19].